- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on PK, PD, and Safety in New Zealand
Total 51 results
-
Holbaek SygehusRegion ZealandRecruitingSafety Issues | Musculoskeletal Disorder | Mental Health Issue | Work-related Illness | Work Environment Adverse EffectsDenmark
-
Island PharmaceuticalsBeyond Drug DevelopmentCompletedSafety and TolerabilityAustralia
-
GE Healthcarei3 StatprobeCompletedPatient Comfort and SafetyUnited States
-
EndologixActive, not recruitingSafety and Performance of the Nellix Endovascular Sealing SystemGermany, Latvia, Luxembourg, Netherlands, New Zealand, Norway, Sweden, United Kingdom
-
Icahn School of Medicine at Mount SinaiRecruitingCancer | Thyroid | PD-1United States
-
University Hospital, Basel, SwitzerlandCompletedPostoperative Complications | Intraoperative Complications | Patient Safety | Risk ManagementNew Zealand, Switzerland, United States, Netherlands, Spain, Austria, Turkey, United Kingdom, Australia, Greece, Ireland, Italy
-
Columbia UniversityCenters for Disease Control and PreventionCompleted
-
Rutgers, The State University of New JerseyCompletedFrail Elderly | Food Safety | Nutritive Value | Homebound PersonsUnited States
-
Biotronik, Inc.TerminatedSafety and Effectiveness of the Siello S LeadUnited States
-
Sarah GoldbergMirati Therapeutics Inc.TerminatedLung Diseases | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Metastatic Lung Non-Small Cell Carcinoma | PD-L1 Gene Mutation | Pembrolizumab | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Advanced Treatment-Naïve PD-L1 | SitravatinibUnited States
-
Vanda PharmaceuticalsCompletedSafety and Tolerability of IloperidoneUnited States
-
Biotronik SE & Co. KGCompletedSafety of MR (Magnetic Resonance) Conditional CRT-pacemakers and ICDsFrance, Germany, Hungary, Canada, Australia, Austria, Czech Republic, Switzerland
-
Dr. Florian PiekarskiCompletedPatient Safety | Patient Blood ManagementGermany
-
Population Health Research InstituteCharles University, Czech Republic; Centre hospitalier de l'Université de Montréal... and other collaboratorsCompletedthe Efficacy and Safety of Off-pump CABGCanada, China, Colombia, India, Chile, Argentina, Brazil, Czech Republic, France, Italy, Poland, Turkey, United Kingdom
-
Icahn School of Medicine at Mount SinaiTerminatedPostoperative Delirium | Postoperative Cognitive Dysfunction | PD | POCDUnited States
-
Lumenis Be Ltd.CompletedTo Verify Tissue Heating and Temperature Stability and Safety Throughout RF Treatment Duration Applied on the FaceUnited States
-
University of FloridaNational Institute on Aging (NIA)RecruitingMentoring | Accidental Fall | Hospital Acquired Condition | Patient Safety | Clinical AlarmsUnited States
-
Albert Einstein College of MedicineRecruitingSafety and Efficacy of Radiation Therapy for the Treatment of KeloidsUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute on Aging (NIA)CompletedPostoperative Delirium | Postoperative Cognitive Dysfunction | PD | POCDUnited States
-
AbbVieActive, not recruitingParkinson's Disease (PD)United States, Australia
-
iPACES LLCAlbany Medical College; 1st Playable Productions; Pacific Brain Health Center; Adirondack... and other collaboratorsNot yet recruitingParkinson's Disease | Mild Cognitive Impairment | MCI | PDUnited States
-
AbbVieCompletedParkinson's Disease (PD)United States, Australia
-
Gilead SciencesMerck Sharp & Dohme LLCRecruitingTriple Negative Breast Cancer | PD-L1 PositiveUnited States, Taiwan, Belgium, Australia, Austria, Israel, Spain, Italy, Korea, Republic of, Japan, France, Netherlands, Canada, Turkey, Germany, Malaysia, Singapore, United Kingdom, Hong Kong, Hungary, Mexico, Switzerland, Puerto... and more
-
Gilead SciencesRecruitingTriple Negative Breast Cancer | PD-L1 NegativeUnited States, Hong Kong, Belgium, Australia, Austria, Israel, Spain, Korea, Republic of, Taiwan, China, Japan, Netherlands, Brazil, Canada, Turkey, France, Germany, Malaysia, United Kingdom, Singapore, Hungary, Mexico, Italy, Switzer... and more
-
AbbVieCompleted
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
-
Hospital for Special Surgery, New YorkAngiocrine BioscienceActive, not recruitingRotator Cuff Tears | Muscle Atrophy or Weakness | Safety Issues | Tendon Rupture - ShoulderUnited States
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, United States, Spain, France, Italy, Korea, Republic of, Poland
-
Novartis PharmaceuticalsCompletedLong-term Safety of TIPItaly, Spain, Germany, United States, Australia, Canada, Hungary, Mexico, Argentina
-
Spero TherapeuticsRecruitingNontuberculous Mycobacterial Pulmonary Disease (NTM-PD)United States
-
AbbVieActive, not recruitingParkinson's Disease (PD)United States, Australia, Belgium, Canada, Denmark, Germany, Italy, Japan, Netherlands, Russian Federation, Spain, Sweden, United Kingdom
-
RWTH Aachen UniversityTerminatedEfficacy and Safety of Xenon Inhalation | Successful Cardiopulmonary Resuscitation | Addition to Therapeutical HypothermiaGermany
-
Boehringer IngelheimCompletedEarly Parkinson Disease (Early PD)United States, Argentina, Austria, Czech Republic, Finland, Germany, Hungary, India, Japan, Malaysia, Russian Federation, Slovakia, Taiwan, Ukraine
-
AbbVieCompletedParkinson's Disease (PD)United States, Australia, Belgium, Canada, Denmark, Germany, Italy, Japan, Netherlands, Russian Federation, Spain, Sweden, United Kingdom
-
ACADIA Pharmaceuticals Inc.CompletedTreatment of Depression in Adults With Parkinson's Disease (PD)United States
-
AmgenCompletedEvaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With | Glucocorticoid-induced OsteoporosisUnited States, Bulgaria, Turkey, Italy, Australia, Belgium, Canada, Colombia, India, Mexico, Peru, Russian Federation, Ukraine
-
AstraZenecaCompletedMetastatic Castrate-Resistant Prostate Cancer (mCRPC), | Efficacy, | Safety and Tolerability, | Pharmacokinetics, | Pharmacodynamics, | Tumour Response.United Kingdom, United States
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingNSCLC | Lung Cancer | Non-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | PD-L1 Gene Mutation | Non-small Cell Lung Cancer Stage IIIA | Non-small Cell Lung Cancer Stage IIUnited States
-
Axcella Health, IncCompletedSickle Cell Disease | Anemia, Sickle Cell | Sickle Cell Anemia | To Assess the Safety and Tolerabiltiy of an Amino Acid Composition in Subjects With Sickle Cell Disease | Sickle Cell DisordersUnited States
-
Theravance BiopharmaTerminatedParkinson's Disease (PD) | MSA | Symptomatic Neurogenic Orthostatic Hypotension | Pure Autonomic Failure (PAF)United States, Spain, United Kingdom, Canada, France, Estonia, Australia, Israel, Denmark, Italy, Poland, New Zealand, Germany, Ukraine, Austria, Bulgaria, Portugal, Hungary, Russian Federation
-
Yale UniversityMerck Sharp & Dohme LLCRecruitingPembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell CarcinomaMelanoma | Renal Cell Carcinoma | Metastatic Melanoma | Brain Metastases | Pembrolizumab | Lenvatinib | PD1/PD-L1 ExperiencedUnited States
-
Adamas Pharmaceuticals, Inc.CompletedParkinson's Disease (PD) | Dyskinesia | Levodopa Induced Dyskinesia (LID)France, Spain, United States, Canada, Germany, Austria
-
AstraZenecaPRA Health SciencesCompletedRecurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and NeckUnited States, Belgium, Canada, France, Spain, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Germany, Georgia, Israel, Czechia
-
Molecular NeuroImagingInstitute for Neurodegenerative DisordersCompletedAlzheimer's Disease (AD) | Tauopathies | Parkinson's Disease (PD) | Progressive Supranuclear Palsy (PSP) | Chronic Traumatic Encephalopathy (CTE) | Frontal Temporal Dementia (FTD) | Pick's DiseaseUnited States
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
University of North Carolina, Chapel HillEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedSexually Transmitted Diseases | Adherence, Medication | Safe SexUnited States
-
Roswell Park Cancer InstituteRecruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Recurrent Head and Neck Squamous... and other conditionsUnited States
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
Incyte CorporationActive, not recruitingCervical Cancer | Nasopharyngeal Carcinoma | Mesothelioma | Advanced Solid Tumor | Small-cell Lung Cancer | Esophageal Squamous Cell Carcinoma | Urothelial Carcinoma | Merkel Cell Carcinoma | HepatoCellular Carcinoma | Cutaneous Squamous Cell Carcinoma | MSI-H/dMMR Tumors | PD-L1 Amplified Tumor (9p24.1)France, United States, Japan, Belgium, Australia
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingNausea | Constipation | Diarrhea | Purpura | Lymphadenopathy | Gastrointestinal Hemorrhage | Hepatomegaly | Primary Systemic Amyloidosis | Amorphous, Eosinophilic, and Acellular Deposit | Early Satiety | Macroglossia | Recurrent Primary Amyloidosis | Refractory Primary AmyloidosisUnited States